| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $575.7M | -20.7% |
| Cost of Revenue | $365.1M | -15.3% |
| Gross Profit | $210.6M | -28.6% |
| R&D Expense | $8.8M | +26.2% |
| SG&A Expense | $76.7M | +6.4% |
| Operating Income | -$40.3M | -72.4% |
| Interest Expense | $3.5M | +88.9% |
| Income Tax | $212.9M | — |
| Net Income | -$89.7M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $41.8M | -54.4% |
| Accounts Receivable | $34.6M | +35.9% |
| Inventory | $73.2M | -25.8% |
| Current Assets | $161.5M | -29.6% |
| Total Assets | $433.3M | -32.6% |
| Current Liabilities | $97.3M | -31.5% |
| Long-term Debt | $24.7M | -73.8% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$28.8M | +6.9% |
| Capital Expenditures | $35.4M | -34.4% |
| Investing Cash Flow | -$34.5M | +39.5% |
| Financing Cash Flow | $13.4M | -76.3% |
| Free Cash Flow | -$64.1M | +24.4% |
| -2325.0% |
| EPS (Basic) | -$1.10 | -1933.3% |
| EPS (Diluted) | -$1.10 | -266.7% |
| Total Liabilities |
| $254.4M |
| -48.7% |
| Stockholders' Equity | $178.0M | +22.1% |